Company: MDCXW
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001062993-25-011673
Chunk: 86

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 86
---
isable.

(10)Includes 32,500 Common Shares underlying stock options that are currently exercisable.

(11)Includes 32,500 Common Shares underlying stock options that are currently exercisable.

(12)Includes 2,914,330 Common Shares held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani's address is 1100 Stonegate Manor, Cheswick, PA 15024.

(13)Includes 2,000,000 Common Shares held of record by 215 Capital Togo PHL Fund I, LP, an entity controlled by Ajay Raju.

(14)Includes 1,266,000 Common Shares held of record by Armistice Capital, LLC, an entity controlled by Steven Boyd. Steven Boyd's address is 510 Madison Avenue, 7th floor New York, New York 10022.

(15)Includes 800,952 Common Shares held of record by SkinJect Partners LLC, an entity controlled by John Hathaway. John Hathaway's address is 285 Kappa Drive, Suite 100, Pittsburgh, PA 15238.

Based upon a review of the information provided to us by our transfer agent, as of June 2, 2025, there were approximately 125 record holders of our Common Shares and one holder of record of our Public Warrants and one holder of record of our warrants issued under the Regulation A offering completed on March 10, 2025. Such numbers do not include beneficial owners holding our securities through nominee names.

<div align='center'>INDEBTEDNESS OF DIRECTORS AND EXECUTIVE OFFICERS</div>

As of the date of this offering circular, no director or officer of the Company, or any associate or affiliate of any of them is indebted to the Company, nor is any indebtedness of any such person the subject of a guarantee, support agreement, letter of credit or other similar arrangement or understanding provided by the Company.

<div align='center'>INTERESTS OF INFORMED PERSONS IN MATERIAL TRANSACTIONS</div>

Other than as set forth herein, the Company is not aware of any material interest, direct or indirect, of any "informed person" of the Company, any proposed director of the Company or any associate or affiliate of any of the foregoing in any transaction since the commencement of the Company's most recently completed financial year or in any proposed transaction which has materially affected or would materially affect the Company or any of